190 related articles for article (PubMed ID: 29121168)
1. δ-Tocopherol inhibits the development of prostate adenocarcinoma in prostate specific Pten-/- mice.
Wang H; Yang X; Liu A; Wang G; Bosland MC; Yang CS
Carcinogenesis; 2018 Feb; 39(2):158-169. PubMed ID: 29121168
[TBL] [Abstract][Full Text] [Related]
2. δ-Tocopherol inhibits receptor tyrosine kinase-induced AKT activation in prostate cancer cells.
Wang H; Hong J; Yang CS
Mol Carcinog; 2016 Nov; 55(11):1728-1738. PubMed ID: 26465359
[TBL] [Abstract][Full Text] [Related]
3. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
4. δ-Tocotrienol is the Most Potent Vitamin E Form in Inhibiting Prostate Cancer Cell Growth and Inhibits Prostate Carcinogenesis in Ptenp-/- Mice.
Wang H; Yan W; Sun Y; Yang CS
Cancer Prev Res (Phila); 2022 Apr; 15(4):233-245. PubMed ID: 35144931
[TBL] [Abstract][Full Text] [Related]
5. Dietary tocopherols inhibit PhIP-induced prostate carcinogenesis in CYP1A-humanized mice.
Chen JX; Li G; Wang H; Liu A; Lee MJ; Reuhl K; Suh N; Bosland MC; Yang CS
Cancer Lett; 2016 Feb; 371(1):71-8. PubMed ID: 26582657
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.
Axanova LS; Chen YQ; McCoy T; Sui G; Cramer SD
Prostate; 2010 Nov; 70(15):1658-71. PubMed ID: 20583132
[TBL] [Abstract][Full Text] [Related]
7. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract][Full Text] [Related]
8. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
Blando J; Portis M; Benavides F; Alexander A; Mills G; Dave B; Conti CJ; Kim J; Walker CL
Am J Pathol; 2009 May; 174(5):1869-79. PubMed ID: 19395652
[TBL] [Abstract][Full Text] [Related]
9. High-fat diet-induced hyperinsulinemia promotes the development of prostate adenocarcinoma in prostate-specific Pten-/- mice.
Wang H; Yan W; Sun Y; Yang CS
Carcinogenesis; 2022 Jun; 43(5):504-516. PubMed ID: 35104315
[TBL] [Abstract][Full Text] [Related]
10. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
[TBL] [Abstract][Full Text] [Related]
11. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
12. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.
Seshacharyulu P; Rachagani S; Muniyan S; Siddiqui JA; Cruz E; Sharma S; Krishnan R; Killips BJ; Sheinin Y; Lele SM; Smith LM; Talmon GA; Ponnusamy MP; Datta K; Batra SK
Oncogene; 2019 Jun; 38(26):5265-5280. PubMed ID: 30914801
[TBL] [Abstract][Full Text] [Related]
13. Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.
Lee SH; Johnson D; Luong R; Sun Z
J Biol Chem; 2015 Jan; 290(5):2759-68. PubMed ID: 25527506
[TBL] [Abstract][Full Text] [Related]
14. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
[No Abstract] [Full Text] [Related]
15. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
[TBL] [Abstract][Full Text] [Related]
16.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
17. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
18. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.
Ma L; He H; Jiang K; Jiang P; He H; Feng S; Chen K; Shao J; Deng G
Aging (Albany NY); 2020 Apr; 12(7):6352-6369. PubMed ID: 32283544
[TBL] [Abstract][Full Text] [Related]
19. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D
Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785
[TBL] [Abstract][Full Text] [Related]
20. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]